Pivotal Clinical ApS: Financial statements 2022
CVR: 40343040
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Pivotal Clinical ApS (CVR 40343040) has filed annual accounts for 2022. In 2022, the company reported a net result of DKK 366 compared with DKK -366 the year before. Equity in the 2022 report amounted to DKK 50,000. The solvency ratio was 100%.
- Profit/Loss
- DKK 366
- Equity
- DKK 50,000
- Total Assets
- DKK 50,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | - | 366 | 50K | - |
| 2021 | - | - | -366 | 50K | - |
| 2020 | - | - | 0 | 50K | - |
| 2019 | - | - | 0 | 50K | - |
Official annual report
Keep an eye on Pivotal Clinical ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Pivotal Clinical ApS has published its annual report for 2021. The net result was DKK -366.
About Pivotal Clinical ApS
Pivotal Clinical ApS is a Danish company of the type Anpartsselskab based in Herlev, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Ibrahim Naman Farr Juri. The company is owned by Pivotal S.L.. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -75 and a net result of DKK -82 compared with DKK -32 the year before. Equity in the 2025 report amounted to DKK 49,886.
